Global Acne Vulgaris Size 2025, Forecast To 2034
26 Mar, 2025
What Has Been the Progress and Growth of the Acne Vulgaris Market in Recent Years?
The acne vulgaris market has seen considerable growth due to a variety of factors.
• In the past few years, the acne vulgaris market has seen substantial growth. It is expected to expand from $7.94 billion in 2024 to $8.47 billion in 2025, with a compound annual growth rate (CAGR) of 6.7%.
Factors contributing to this leap during the historical interval include the growing occurrence of acne, customer preference towards natural components, development of internet retail channels, funding pumped into research and development, along with the rising availability of over-the-counter products.
What Can Be Expected from the Acne Vulgaris Market in the Coming Years?
The acne vulgaris market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, substantial growth is expected in the acne vulgaris market, which is projected to reach a value of $10.89 billion in 2029, growing at a compound annual growth rate (CAGR) of 6.5%.
Factors contributing to the growth during the forecast period include increased understanding and focus on skincare, a growing teenage demographic, more emphasis on self-care and wellness, increasing instances of adult acne, the rise of telemedicine, and the expansion of e-commerce. Leading trends in this period are technological advancement, debut of advanced medications, innovative products, increased clinical approvals, and breakthroughs in novel medical processes.
What Are the Critical Driver Fuelling The Acne Vulgaris Market's Growth?
The acne vulgaris market is projected to flourish owing to the escalating demand for skincare products. Such products are unique formulations developed to improve skin health and aesthetics, encompassing a vast array of items targeting various skin issues, from cleansing to moisturizing and safeguarding. The amplified demand for these products can be traced back to social media influence, escalating dermatological issues, product innovation, and a shift towards preventative skincare, contributing to heightened skincare awareness. Skincare products play a vital role in acne vulgaris treatment, addressing the primary reasons for the condition like enhanced sebum production, blocked pores, and bacterial growth. They harness components like salicylic acid, benzoyl peroxide, and retinoids that aid in skin exfoliation, reducing inflammation and fostering cleaner, healthier skin. As per The Cosmetic, Toiletry and Perfumery Association (CTPA), a non-profit organization based in the UK, the European cosmetics market in August 2024 was estimated at €96 billion (roughly $105 billion) at retail sales price (RSP) in 2023, positioning it as one of the largest alongside the USA. This was an upsurge from €88 billion (about $93 billion) RSP in 2022. Thus, the booming awareness about skincare is propelling the acne vulgaris market.
How Is The Acne Vulgaris Market segmented?
The acne vulgaris market covered in this report is segmented –
1) By Type: Systemic Therapy, Hormonal Therapy, Physical Treatment, Topical Combination Therapy, Other Types
2) By Age Group: 10 To 17 Years, 18 To 44 Years, 45 To 64 Years, 65 Years And Above
3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies
Subsegments:
1) By Systemic Therapy: Oral Antibiotics, Oral Retinoids, Oral Anti-Inflammatory Agents
2) By Hormonal Therapy: Oral Contraceptives, Androgen Receptor Inhibitors
3) By Physical Treatment: Laser Therapy, Light-Based Therapy, Chemical Peels, Microdermabrasion
4) By Topical Combination Therapy: Retinoid And Antibiotic Combinations, Benzoyl Peroxide And Antibiotic Combinations, Retinoid And Benzoyl Peroxide Combinations
5) By Other Types: Herbal And Natural Remedies, Biologic Therapies, Emerging Therapies
What New Trends Are Influencing The Acne Vulgaris Market?
Leading businesses in the acne vulgaris market are driving innovation by concentrating their efforts on the creation of novel solutions such as triple-combination topical treatment, allowing a simpler, single-daily application method of triple-combination topical treatment for acne vulgaris. The triple-combination topical treatment constitutes a blend of three potent ingredients, typically aimed at addressing various facets of a condition, thus providing improved therapeutic outcomes in treating skin conditions like acne or psoriasis. For instance, Bausch Health Companies Inc., a pharmaceutical corporation headquartered in Canada, received approval from the Food and Drug Administration (FDA) in October 2023, for Cabtreo (clindamycin phosphate, adapalene, and benzoyl peroxide). This topical gel, devised for combating acne vulgaris in patients who are 12 years or older, innovatively amalgamates an antibiotic, a retinoid, and an antibacterial substance, delivering effective results against acne spots and inhibiting further eruptions. Cabtreo's beneficial safety record and ease of application make it suitable for a broad range of patients.
Who Are the Key Players In The Acne Vulgaris Market?
Major companies operating in the acne vulgaris market are:
• Pfizer Inc.
• Johnson and Johnson
• AbbVie Inc.
• L'Oréal Paris
• GlaxoSmithKline Plc.
• Reckitt Benckiser Group plc
• Viatris Inc.
• Teva Pharmaceuticals
• Bausch Healh Companies
• Sun Pharmaceutical Industries Ltd.. Incyte
• Aurobindo Pharma
• Lupin Ltd.
• Torrent Pharmaceuticals
• Biocon
• Stiefel Laboratories
• Mayne Pharma Group Limited
• Paratek Pharmaceuticals
• Cosmo Pharmaceuticals
• AOBiome
What Is The Most Dominant Region In The Acne Vulgaris Market?
North America was the largest region in the acne vulgaris market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the acne vulgaris market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.